HSBC Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $835K | Sell |
38,631
-24,686
| -39% | -$534K | ﹤0.01% | 1470 |
|
|
2025
Q1 | $1.04M | Sell |
63,317
-5,704
| -8% | -$93.4K | ﹤0.01% | 1342 |
|
|
2024
Q4 | $1.27M | Buy |
69,021
+4,025
| +6% | +$74.3K | ﹤0.01% | 1342 |
|
|
2024
Q3 | $1.01M | Buy |
64,996
+51,448
| +380% | +$796K | ﹤0.01% | 1368 |
|
|
2024
Q2 | $220K | Buy |
13,548
+407
| +3% | +$6.61K | ﹤0.01% | 2138 |
|
|
2024
Q1 | $243K | Buy |
+13,141
| New | +$243K | ﹤0.01% | 2166 |
|
|
2022
Q3 | – | Sell |
-10,566
| Closed | -$149K | – | 2431 |
|
|
2022
Q2 | $149K | Sell |
10,566
-2,275
| -18% | -$32.1K | ﹤0.01% | 2523 |
|
|
2022
Q1 | $314K | Buy |
+12,841
| New | +$314K | ﹤0.01% | 2361 |
|
|
2021
Q3 | – | Sell |
-27,563
| Closed | -$681K | – | 2481 |
|
|
2021
Q2 | $681K | Buy |
27,563
+6,343
| +30% | +$157K | ﹤0.01% | 1601 |
|
|
2021
Q1 | $545K | Buy |
21,220
+14,768
| +229% | +$379K | ﹤0.01% | 1603 |
|
|
2020
Q4 | $345K | Sell |
6,452
-11,038
| -63% | -$590K | ﹤0.01% | 2056 |
|
|
2020
Q3 | $720K | Sell |
17,490
-3,675
| -17% | -$151K | ﹤0.01% | 1351 |
|
|
2020
Q2 | $1.03M | Buy |
21,165
+15,728
| +289% | +$762K | ﹤0.01% | 1128 |
|
|
2020
Q1 | $230K | Sell |
5,437
-12,492
| -70% | -$528K | ﹤0.01% | 1798 |
|
|
2019
Q4 | $762K | Buy |
17,929
+9,970
| +125% | +$424K | ﹤0.01% | 1486 |
|
|
2019
Q3 | $286K | Buy |
+7,959
| New | +$286K | ﹤0.01% | 2067 |
|
|
2019
Q2 | – | Sell |
-7,896
| Closed | -$212K | – | 2090 |
|
|
2019
Q1 | $212K | Buy |
+7,896
| New | +$212K | ﹤0.01% | 1998 |
|
|
2018
Q1 | – | Sell |
-13,557
| Closed | -$408K | – | 1944 |
|
|
2017
Q4 | $408K | Buy |
+13,557
| New | +$408K | ﹤0.01% | 1486 |
|